Comparison of two strategies to reduce the pain associated with intravenous administration of rocuronium.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2009/091/000002

Enrollment

120

Registered

2009-02-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Lignocaine: 30 mg IV in experimental vein Intervention2: Clonidine: 30 mcg IV in experimental vein Control Intervention1: saline: 3 ml

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both sexes of ASA grade 1 & 2, Age 18-55 years, Patients undergoing general anesthesia for elective general, gynaecologic, orthopaedic, urologic, plastic, spine, ophthalmic, ENT surgeries

Exclusion criteria

Exclusion criteria: (1) Age less than18 years or more than 55 years. (2) ASA grade 3 or more. (3) Patients with history of allergy to study medications. (4) Patients with any psychiatric illness. (5) Patients receiving analgesics or sedatives.

Design outcomes

Primary

Measure	Time frame
pain on injection of sub-paralyzing dose of rocuroniumTimepoint: immediately after injection.	—

Secondary

Measure	Time frame
withdrawl movement after injection of paralyzing dose of rocuroniumTimepoint: immediately after induction of anesthesia with thiopentone sodium	—

Countries

India

Contacts

Public ContactDr. Ashish jain

drashishjain07@rediffmail.com01412708307

Outcome results